Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
First published: 13 January 2021
In Cullen et al,1 the original figure mixed up the color labels of “Preclinical AD” and “Mild AD.” This has now been fixed in the new figure, and the authors apologize for this error (Figure 1).
Figure 1
Longitudinal trajectories of pNfL across groups. This figure shows the predicted longitudinal trajectories of pNfL, AD-signature cortical thickness temporal composite, bilateral hippocampal volume, CDRSB, and PACC.
